To the best of our knowledge, our results clarify for the first time that (1) CCN1 inhibition possesses an anti–cardiac remodeling role in CKD and (2) provide data to support the underlying mechanism of the crosstalk between the kidney and heart. The gene discussed is CCN1; the disease is chronic kidney disease.